News

Filter

1 to 9 of 11 results

Nippon Boeh Ing again records fastest growth in Japan's ethical drug market

28-04-2008

The Japanese subsidiary of Boehringer Ingelheim, the privately-owned German pharmaceutical major, is…

AggrenoxAspirinBayerBoehringer IngelheimDipyridamoleExtended-Release DipyridamoleMicardisNystatinOralPersantineSpirivaTelmisartantiotropium

Barr challenges Boeh Ing's Aggrenox patent

23-07-2007

US generics group Barr Laboratories says it has initiated a challenge of the patent listed by independent…

AggrenoxAspirinBarr LaboratoriesBayerBoehringer IngelheimDipyridamoleExtended-Release DipyridamolePersantine

R&D continues to be key for Germany's Boehringer Ingelheim

02-04-2007

German, privately-owned drugmaker Boehringer Ingelheim reiterated the importance of research during its…

AggrenoxAptivusAspirinBayerBoehringer IngelheimDipyridamoleExtended-Release DipyridamoleMicardisMirapexPersantinePfizerPramipexolesildenafilSpirivaTelmisartantiotropiumTipranavirViagra

Record growth for Boeh Ing Japan

01-05-2006

Nippon Boehringer Ingelheim, the Japanese subsidiary of German independent drugmaker Boehringer Ingelheim,…

AggrenoxAspirinBayerBoehringer IngelheimDipyridamoleExtended-Release DipyridamoleMexiletine HClMexitilMicardisPersantineSpirivaTelmisartantiotropium

Boeh Ingelheim launches largest-ever stroke prevention trial with dipyridamole

02-06-2003

New scientific approaches for the prevention and acute treatment of stroke were the focus at the 12th…

ActivaseAggrenoxAlteplaseAspirinBoehringer IngelheimDipyridamoleExtended-Release DipyridamoleGenentechMicardisPersantineTelmisartan

BI's Aggrenox OKed in USA

25-11-1999

A new drug combination for the prevention of stroke in patients who haveexperienced a previous stroke…

AggrenoxAspirinBayerDipyridamoleExtended-Release DipyridamolePersantine

1 to 9 of 11 results

COMPANY SPOTLIGHT

Menarini

Back to top